RS50305B - 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja - Google Patents
4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenjaInfo
- Publication number
- RS50305B RS50305B YUP-164/03A YUP16403A RS50305B RS 50305 B RS50305 B RS 50305B YU P16403 A YUP16403 A YU P16403A RS 50305 B RS50305 B RS 50305B
- Authority
- RS
- Serbia
- Prior art keywords
- halogenated
- compounds
- production
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000002577 pseudohalo group Chemical group 0.000 abstract 2
- NVISWEPHXBNEQS-PSYRKBHYSA-N (8s,9s,10r,13s,14s)-4-chloro-10,13-dimethyl-17-methylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=C)[C@@H]4[C@@H]3CCC2=C1Cl NVISWEPHXBNEQS-PSYRKBHYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
17-Metilen steroidi opšte formule I u kojima R4 stoji za halogeni atom ili pseudohalogen, R10 stoji za atom vodonika ili sa lancem u normalnom nizu ili račvastu C1-C4 alkil grupu, R20 i R20a, nezavisno jedan od drugog, predstavljaju atom vodonika, sa lancem u normalnom nizu ili račvastu C1-C4 alkil ili hidroksi- C1-C4 alkil grupu, ili jedan od radikala R20 i R20a znači atom vodonika, sa lancem u normalnom nizu ili račvastu C1-C4 alkil ili hidroksi- C1-C4 alkil grupa, a drugi radikal znači halogeni atom ili pseudohalogen, sa izuzetkom sledećih jedinjenja: 4-hloro-17-metilen-4-androsten-3-on i 4-hloro-20ξ-fluoro-hidroksipregna-4-17(20)-dien-3-on. Prijava sadrži još 9 zahteva
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10043846A DE10043846A1 (de) | 2000-09-04 | 2000-09-04 | 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU16403A YU16403A (sh) | 2006-05-25 |
| RS50305B true RS50305B (sr) | 2009-09-08 |
Family
ID=7655148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YUP-164/03A RS50305B (sr) | 2000-09-04 | 2001-08-29 | 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1423407B1 (sr) |
| JP (1) | JP2004513084A (sr) |
| KR (1) | KR100530816B1 (sr) |
| CN (1) | CN1262560C (sr) |
| AT (1) | ATE319733T1 (sr) |
| AU (2) | AU2002210470B2 (sr) |
| BG (1) | BG107594A (sr) |
| BR (1) | BR0113618A (sr) |
| CA (1) | CA2421302C (sr) |
| DE (2) | DE10043846A1 (sr) |
| DK (1) | DK1423407T3 (sr) |
| EA (1) | EA006387B1 (sr) |
| EE (1) | EE05186B1 (sr) |
| ES (1) | ES2260294T3 (sr) |
| HK (1) | HK1060135A1 (sr) |
| HR (1) | HRP20030256A2 (sr) |
| HU (1) | HUP0300936A3 (sr) |
| IL (2) | IL154666A0 (sr) |
| ME (1) | MEP14408A (sr) |
| MX (1) | MXPA03001912A (sr) |
| NO (1) | NO325012B1 (sr) |
| NZ (1) | NZ524485A (sr) |
| PL (1) | PL360669A1 (sr) |
| PT (1) | PT1423407E (sr) |
| RS (1) | RS50305B (sr) |
| SK (1) | SK286757B6 (sr) |
| UA (1) | UA74592C2 (sr) |
| WO (1) | WO2002019971A1 (sr) |
| ZA (1) | ZA200301715B (sr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10141984A1 (de) | 2001-08-28 | 2003-03-20 | Jenapharm Gmbh | Neue 17-Methylen-4-azasteroide |
| US7199115B2 (en) | 2004-04-19 | 2007-04-03 | Schering Ag | 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them |
| EP2055306A1 (de) * | 2007-11-05 | 2009-05-06 | Bayer Schering Pharma AG | Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2611773A (en) * | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
| US3146239A (en) * | 1957-09-23 | 1964-08-25 | Syntex Corp | 4-halo-19-nor-progesterone |
| US3232960A (en) * | 1959-10-08 | 1966-02-01 | Upjohn Co | 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process |
| US3661940A (en) * | 1970-04-13 | 1972-05-09 | Sandoz Ag | Derivatives of 21-methyl-19-norpregnanes |
| US4389345A (en) * | 1981-10-09 | 1983-06-21 | G.D. Searle & Co. | 3-Oxoestra-17-acetonitrile and unsaturated analogs |
| US5994334A (en) * | 1997-02-05 | 1999-11-30 | University Of Maryland | Androgen synthesis inhibitors |
| AU2001268661A1 (en) * | 2000-06-27 | 2002-01-08 | Aventis Pharma S.A. | 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
-
2000
- 2000-09-04 DE DE10043846A patent/DE10043846A1/de not_active Ceased
-
2001
- 2001-08-29 EE EEP200300087A patent/EE05186B1/xx not_active IP Right Cessation
- 2001-08-29 NZ NZ524485A patent/NZ524485A/en unknown
- 2001-08-29 RS YUP-164/03A patent/RS50305B/sr unknown
- 2001-08-29 PL PL36066901A patent/PL360669A1/xx unknown
- 2001-08-29 CN CNB018151345A patent/CN1262560C/zh not_active Expired - Fee Related
- 2001-08-29 HU HU0300936A patent/HUP0300936A3/hu unknown
- 2001-08-29 AT AT01978315T patent/ATE319733T1/de not_active IP Right Cessation
- 2001-08-29 KR KR10-2003-7003170A patent/KR100530816B1/ko not_active IP Right Cessation
- 2001-08-29 MX MXPA03001912A patent/MXPA03001912A/es active IP Right Grant
- 2001-08-29 SK SK244-2003A patent/SK286757B6/sk not_active IP Right Cessation
- 2001-08-29 EA EA200300322A patent/EA006387B1/ru not_active IP Right Cessation
- 2001-08-29 WO PCT/EP2001/009943 patent/WO2002019971A1/de active IP Right Grant
- 2001-08-29 AU AU2002210470A patent/AU2002210470B2/en not_active Ceased
- 2001-08-29 UA UA2003042852A patent/UA74592C2/uk unknown
- 2001-08-29 DK DK01978315T patent/DK1423407T3/da active
- 2001-08-29 EP EP01978315A patent/EP1423407B1/de not_active Expired - Lifetime
- 2001-08-29 PT PT01978315T patent/PT1423407E/pt unknown
- 2001-08-29 IL IL15466601A patent/IL154666A0/xx unknown
- 2001-08-29 AU AU1047002A patent/AU1047002A/xx active Pending
- 2001-08-29 JP JP2002524456A patent/JP2004513084A/ja active Pending
- 2001-08-29 CA CA002421302A patent/CA2421302C/en not_active Expired - Fee Related
- 2001-08-29 ME MEP-144/08A patent/MEP14408A/xx unknown
- 2001-08-29 DE DE50109175T patent/DE50109175D1/de not_active Expired - Lifetime
- 2001-08-29 BR BR0113618-6A patent/BR0113618A/pt not_active IP Right Cessation
- 2001-08-29 ES ES01978315T patent/ES2260294T3/es not_active Expired - Lifetime
-
2003
- 2003-02-27 IL IL154666A patent/IL154666A/en not_active IP Right Cessation
- 2003-02-27 BG BG107594A patent/BG107594A/bg unknown
- 2003-02-28 ZA ZA200301715A patent/ZA200301715B/en unknown
- 2003-03-03 NO NO20030989A patent/NO325012B1/no not_active IP Right Cessation
- 2003-04-04 HR HR20030256A patent/HRP20030256A2/hr not_active Application Discontinuation
-
2004
- 2004-04-27 HK HK04102956A patent/HK1060135A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL350075I2 (sr) | ||
| BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
| TR199900920T2 (xx) | Nafthiridin t�revleri. | |
| GT200000103A (es) | Trifluorbutenos nematocidas. | |
| JO2654B1 (en) | Multiple aryl caroxa amides are useful as lipid - lowering agents | |
| MXPA05010652A (es) | Pirazoles sustituidos. | |
| TR200202806T2 (tr) | 4-Triflorometilsulfinilpirazol türevi hazırlama süreci | |
| HUP0300434A2 (hu) | Oxazolszármazékok és alkalmazásuk tirozin-kináz-inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| BG106440A (en) | Nitrogen-heterocyclic derivatives as nos inhibitors | |
| HUP0004592A2 (hu) | VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások | |
| AU1529402A (en) | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor | |
| MXPA02011370A (es) | Iminoazinas substituidas. | |
| TR200301723T4 (tr) | 1,3 Dihidro-2H-indol-2 one türevleri ve bunların, arginin-vasopressin' in V1B veya V1B reseptörleri için bağ maddeleri olarak kullanımı | |
| TNSN03117A1 (en) | Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands | |
| MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
| TR200401052T4 (tr) | Yeni bileşikler | |
| GB9711123D0 (en) | Novel cyanoguanidines | |
| RS50305B (sr) | 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja | |
| MXPA05010650A (es) | Pirazoles sustituidos. | |
| HUP0402033A2 (hu) | 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| DE60001366D1 (de) | Orale zusammensetzung enthaltend perlit | |
| MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
| DE59803066D1 (de) | Substituierte benzyloxyimino-verbindungen | |
| FI964278A0 (fi) | Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdannaisten valmistamiseksi | |
| NO994104L (no) | 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler |